ReviewDiscover oncology2024

Nanoquercetin based nanoformulations for triple negative breast cancer therapy and its role in overcoming drug resistance.

Adyasa Samantaray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.